Clinical researech technology provider Clinerion and Semicrol, the creator of Fundanet CTMS, will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s CTMS product.
Clinical researech technology provider Clinerion and Semicrol, the creator of Fundanet CTMS, will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s CTMS product. The partnership will integrate patient data throughout the clinical trial process, from planning to reporting of results, and enable automated sharing of patient data from a hospital’s electronic health records system to the CTMS running a clinical trial at that hospital. The goal is to enable efficient trial processes and patient outcomes that preserve patient data privacy, while patient data remains within the hospital IT infrastructure throughout.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.